CSBR - Company ID 0000771856
The table below shows CHAMPIONS ONCOLOGY, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$492.00K | $600.00K | $311.00K | -$3.99M | -$195.00K | $216.00K |
| Capital expenditure | $55.00K | $46.00K | $0.00 | $668.00K | $754.00K | $907.00K |
| Investing cash flow | -$55.00K | -$46.00K | $0.00 | -$668.00K | -$754.00K | -$907.00K |
| Dividends paid | - | - | - |
CHAMPIONS ONCOLOGY, INC. reported operating cash flow of -$4.47M for fiscal year 2026. That is down 160.5% from $7.39M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow declined from -$2.84M (FY 2017) to -$4.47M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | $0.00 | $602.00K | $0.00 | - |
| Financing cash flow | $33.00K | -$14.00K | -$37.00K | -$590.00K | $0.00 | $2.00K |